AFLD 2009 FFFA vs Respondent M43

Facts
The French Football Federation (Fédération Française de Football Américain, FFFA) charges respondent M43 for a violation of the Anti-Doping Rules. During a match on February 23, 2009, a sample was taken for doping control purposes. The analysis showed the presence of salbutamol. Salbutamol is a prohibited substance according the World Anti Doping Agency (WADA) prohibited list and is regarded as a specified substance.

History
The respondent had used medication that contained the prohibited substance, he used it to treat a condition of his bronchi. The respondent sent several medical documents, a copy of the request for a therapeutic use exemption (TUE) and the results of two pulmonary function tests to the l'Agence française de lutte contre le dopage (AFLD). However the specific documents for getting approval are not enclosed. The measured level of salbutamol contradicts the medical use.

Decision
1. The sanction is a period of ineligibility of one year in which respondent can't take part in competition or manifestations organized or authorized by the FFFA.
2. The decision (six months period of ineligibility as well as training lead) dated May 6, 2009, by the disciplinary committee of the FFFA should be modified.
3. The period of ineligibility should be reduced by the period already served in voluntary suspension and by the decision of May 6, 2009.
4. The decision starts on the date of notification.
5. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
26 November 2009
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Period of ineligibility
Sport/IFs
American Football (IFAF) - International Federation of American Football
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française de Football Américain (FFFA) - French Federation of American Football
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S3. Beta-2 Agonists
Substances
Salbutamol
Medical terms
Respiratory disease
Therapeutic Use Exemption (TUE)
Treatment / self-medication
Document type
Pdf file
Date generated
17 June 2014
Date of last modification
25 August 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin